Five Key Facts About Immigrants with Limited English Proficiency
This brief presents 5 key facts about immigrants with limited English proficiency, drawing from the KFF/ LA Times Survey of Immigrants.
View the Latest: Access to Care
Filter
-
-
KFF Examines the Hyde Amendment and its Impact in States Without Abortion Bans
News ReleaseKFF takes a new look at the continued impact of the Hyde Amendment, the federal ban on payment for abortion services, in the wake of the Supreme Court’s Dobbs decision. At a moment when all eyes are on states that have banned abortion, the Hyde Amendment remains a barrier to abortion care for people with low incomes in states where abortion is legal but the state restricts Medicaid coverage to the narrow exceptions allowed under…
-
The Hyde Amendment and Coverage for Abortion Services Under Medicaid in the Post-Roe Era
Issue BriefThis brief details the federal programs that are affected by the Hyde Amendment and laws and regulations that have a similar goal, provides estimates on the share of women insured by Medicaid affected by the law, reviews the impact of the law on their access to abortion services, and discusses the potential effect if the law were to be repealed.
-
A Closer Look at Medicaid Expansion Efforts in Mississippi
Policy WatchThis policy watch examines Mississippi's recent Medicaid expansion activity, what expansion could mean for residents and the economy, and key developments to watch.
-
Charges for Emails with Doctors and other Healthcare Providers
Issue BriefPatient-provider email messaging accelerated early in the COVID-19 pandemic as more patients sought medical care remotely, and the addition of billing codes for digital health services and subsequent changes in insurers’ payment policies have enabled providers to bill insurers and patients for messaging. This analysis examines the typical cost of patient-provider email messaging in 2020 and 2021 using private health insurance claims data. The typical cost for an email messaging claim was $39 in 2021,…
-
Section 1115 Medicaid Waiver Watch: A Closer Look at Recent Approvals to Address Health-Related Social Needs (HRSN)
Issue BriefThis issue brief provides an overview of how Section 1115 waivers have been used to address the health-related social needs of enrollees, including a summary of recent approvals for eight states.
-
Want to Learn About Women’s Health in your State? Check out KFF’s Updated Interactive Dashboard
News ReleaseKFF recently updated its interactive dashboard with national and state data on women’s health, as well as information about various policies that affect women’s health. The dashboard provides instant access the most up-to-date state level indicators of women’s health in the U.S. Many of the indicators also provide national and state-level information for women of different racial and ethnic groups. Dashboard topics include: Abortion availability, coverage, and use by race/ethnicity. Maternal and infant mortality, preterm…
-
Racial and Ethnic Disparities in Access to Medical Advancements and Technologies
Issue BriefThis brief provides an overview of diversity in clinical trials, disparities in access to novel drug therapies and other treatments, and the implications for health and health care.
-
Commercialization of COVID-19 Vaccines, Treatments, and Tests: Implications for Access and Coverage
Issue BriefWith the depletion of the federal-purchased supply of COVID-19 vaccines, treatments and tests following the end of the public health emergency, this resource provides an overview of the implications of these changes for access to people covered by Medicare, Medicaid and private insurance, as well as those who are uninsured.
-
State Approaches to Addressing the Opioid Epidemic: Findings from a Survey of State Medicaid Programs
Issue BriefState Medicaid programs are taking steps to address the opioid epidemic. State Medicaid efforts include improving access to OUD treatment medications, covering over the counter Narcan, and extending OUD treatment to soon-to-be-released inmates--a population at high risk of overdose death upon release.